Table 29.
Occurrence of resistance to selected antimicrobials in Campylobacter jejuni from calves under 1 year of age, using harmonised ECOFFs, 5 EU MSs, 2017
| Country | N | GEN | STR | NAL | CIP | ERY | TET |
|---|---|---|---|---|---|---|---|
| Croatia | 53 | 77.4 | 81.1 | 100 | 100 | 3.8 | 34.0 |
| Denmark | 236 | 0 | 0.4 | 30.1 | 30.1 | 0.4 | 6.8 |
| Italy | 74 | 5.4 | 13.5 | 77.0 | 78.4 | 1.4 | 91.9 |
| Netherlandsa | 90 | 0 | 1.1 | 25.6 | 23.3 | 1.1 | 17.8 |
| Spain | 132 | 2.3 | 27.3 | 76.5 | 78.8 | 1.5 | 83.3 |
| Total (5 MSs) | 585 | 8.2 | 15.6 | 52.1 | 52.5 | 1.2 | 39.0 |
ECOFFs: epidemiological cut‐off values; MSs: Member States; N: number of isolates tested; CIP: ciprofloxacin; ERY: erythromycin; GEN: gentamicin; NAL: nalidixic acid; STR: streptomycin; TET: tetracycline
a
C. jejuni isolates from cattle tested in the Netherlands in 2017 derive from fattening steers.